Orexo AB (Sweden) Today
| ORX Stock | SEK 14.82 0.22 1.51% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Orexo AB is selling for under 14.82 as of the 17th of March 2025; that is 1.51 percent increase since the beginning of the trading day. The stock's last reported lowest price was 14.6. Orexo AB has about a 40 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. The company has 34.35 M outstanding shares. More on Orexo AB
Moving against Orexo Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Orexo Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Orexo AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Orexo AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres CEO | Nikolaj Sorensen |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Orexo AB (ORX) is traded on Stockholm Exchange in Sweden and employs 126 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 612.75 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Orexo AB's market, we take the total number of its shares issued and multiply it by Orexo AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Orexo AB operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 34.35 M outstanding shares.
Orexo AB has accumulated about 697 M in cash with (156.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Orexo AB Probability Of Bankruptcy
Ownership AllocationOrexo AB owns a total of 34.35 Million outstanding shares. 30% of Orexo AB outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Orexo Ownership Details
Orexo AB Risk Profiles
Although Orexo AB's alpha and beta are two of the key measurements used to evaluate Orexo AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.25 | |||
| Semi Deviation | 3.26 | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.68 |
Orexo Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Orexo AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Orexo AB Corporate Management
Elected by the shareholders, the Orexo AB's board of directors comprises two types of representatives: Orexo AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orexo. The board's role is to monitor Orexo AB's management team and ensure that shareholders' interests are well served. Orexo AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orexo AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fredrik Jarrsten | Ex CFO | Profile | |
| MD MBA | Chief Officer | Profile | |
| Lena Wange | Investor Relations & Communications Manager | Profile | |
| Jesper Lind | Advisor | Profile | |
| Dennis Urbaniak | Ex Therapeutics | Profile |
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.